Skip to main content
. 2024 Aug 19;11(8):843. doi: 10.3390/bioengineering11080843

Table 2.

Baseline characteristics of the study population.

Characteristics All (n = 104) CV Death (n = 24) No-CV Death (n = 80) p-Value
Age (years) 67.1 ± 12.0 75.0 ± 8.5 72.0 ± 12.8 0.37
Male 74/104 (71.15%) 19/24 (79.2%) 52/80 (65.0%) 0.19
Physical Measurement
Height (cm) 171.8 ± 9.8 173.6 ± 5.6 172.3 ± 12.3 0.67
Weight (kg) 93.7 ± 25.3 102.1 ± 36.4 91.1 ± 20.0 0.17
BMI (kg/m2) 31.73 ± 8.1 33.8 ± 12.0 30.8 ± 5.8 0.23
Medical History
Hypertension 99/104 (95.2%) 24/24 (100.0%) 75/80 (93.8%) 0.21
Diabetes Mellitus 56/104 (53.8%) 13/24 (54.2%) 43/80 (53.8%) 0.97
Hyperlipidemia 90/104 (86.5%) 20/24 (83.3%) 70/80 (87.5%) 0.60
Previous PCI 8/104 (7.7%) 3/24 (12.5%) 5/80 (6.3%) 0.31
Previous Myocardial Infarction 60/104 (57.7%) 17/24 (70.8%) 43/80 (53.8%) 0.14
Heart Failure, LVEF < 30% 58/104 (55.8%) 16/24 (66.7%) 42/80 (52.5%) 0.22
Previous CABG 8/104 (7.7%) 2/24 (8.3%) 6/80 (7.5%) 0.89
Current Smoker (≤6 Months) 53/104 (51.0%) 15/24 (62.5%) 38/80 (47.5%) 0.20
Renal Dysfunction (Serum Creatinine > 2.0) 53/104 (51.0%) 16/24 (66.7%) 37/80 (46.3%) 0.08
Hemodialysis or Renal Transplant 12/104 (11.5%) 5/24 (20.8%) 7/80 (8.8%) 0.10
Pre-procedure Presentation
STEMI/Cardiogenic shock 10/104 (9.6%) 2/24 (8.3%) 8/80 (10.0%) 0.81
NSTEMI/Unstable Angina 35/104 (33.7%) 5/24 (20.8%) 30/80 (37.5%) 0.13
Stable Angina 57/104 (54.8%) 13/24 (54.2%) 44/80 (55.0%) 0.94
Aortic stenosis 1/104 (1.0%) 1/24 (4.2%) 0/80 (0%) 0.07